文献速递创伤骨科骨质疏松与代谢性骨病

非典型股骨骨折再手术率升高与患者特征相关而非骨折类型:全国性队列研究

Increased rate of reoperation in atypical femoral fractures is related to patient characteristics and not fracture type. A nationwide cohort study.
PubMed 文献 · Osteoporos Int · 2020-01-13

全国性队列纳入163例非典型骨折与862例普通股骨干/转子下骨折患者,比较再手术风险。非典型骨折任何原因再手术的年龄校正OR为1.76(95%CI 1.08-2.86),但多变量校正后任何再手术的病因特异HR为1.34(95%CI 0.85-2.13),愈合并发症相关再手术HR为1.32(95%CI 0.58-3.0),均无统计学显著性。结论认为再手术风险升高主要由患者特征而非骨折类型解释。

要点

  • 非典型骨折患者年龄校正后任何再手术OR为1.76(95%CI 1.08-2.86)。
  • 多变量校正后任何再手术HR为1.34(95%CI 0.85-2.13),无统计学显著性。
  • 愈合并发症相关再手术HR为1.32(95%CI 0.58-3.0),无统计学显著性。

核心结论

  • 非典型股骨骨折后再手术风险升高主要由患者特征而非骨折类型解释。

研究设计与样本

  • 全国性队列研究纳入163例非典型骨折和862例普通股骨干或转子下骨折患者。
  • 通过影像与登记数据互补审查识别再手术,计算任何再手术及愈合并发症相关再手术风险。

主要发现

  • 非典型骨折患者任何原因再手术的年龄校正OR为1.76(95%CI 1.08至2.86)。
  • 普通骨折患者因死亡率高三倍而随访时间更短。
  • 多变量校正时间-事件模型中,任何再手术的病因特异HR为1.34(95%CI 0.85至2.13),无统计学显著性。
  • 愈合并发症相关再手术的HR为1.32(95%CI 0.58至3.0),无统计学显著性。
  • 骨折后第一年继续使用双膦酸盐未影响再手术率。

临床怎么用

  • 评估非典型股骨骨折再手术风险时应综合考虑年龄和健康状况等患者背景特征。
  • 骨折后第一年继续使用双膦酸盐未显示影响再手术率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Atypical femoral fractures are burdened with a high rate of reoperation. In our nationwide analysis, the increased rate of reoperation was related to patient background characteristics, such as age and health status, rather than fracture type. INTRODUCTION: Patients with atypical fractures are complex to treat and burdened with a high risk of reoperation. We hypothesized that patients with surgically treated, complete atypical fractures have a higher risk of any reoperation and reoperation related to healing complications than patients with common femoral shaft fractures but that this increase would become insignificant when adjusted for predefined characteristics. METHODS: A cohort of 163 patients with atypical fractures and 862 patients with common femoral shaft or subtrochanteric fractures treated from 2008 to 2010 and who had follow-up radiographs and register data available until 31 December 2014 was included. Reoperations were identified by a complementary review of radiographs and register data and were used to calculate risks for any reoperation and reoperations related to healing complications. RESULTS: Patients with atypical fractures were more likely to be reoperated for any reason, age-adjusted OR 1.76 (95% CI, 1.08 to 2.86). However, patients with common fractures had a shorter follow-up due to a threefold higher death rate. Accordingly, in a multivariable-adjusted time-to-event model, the increased risk lost statistical significance for any reoperations, cause-specific HR 1.34 (95% CI, 0.85 to 2.13), and for reoperations related to healing complications, HR 1.32 (95% CI, 0.58 to 3.0). Continued use of bisphosphonate in the first year after the fracture did not affect the reoperation rate. CONCLUSIONS: Our findings suggest that the increased risk of reoperation after an atypical femur fracture is largely explained by patient characteristics and not fracture type.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Bögl HP, Michaëlsson K, Zdolsek G, et al. Increased rate of reoperation in atypical femoral fractures is related to patient characteristics and not fracture type. A nationwide cohort study. Osteoporos Int. 2020. PMID: 31932963. doi:10.1007/s00198-019-05249-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。